Nurix Therapeutics

Filed a patent for "bifunctional compounds for degrading braf via ubiquitin proteosome pathway" on Fri, April 28, 2023

Filed a patent for "bifunctional selective degraders of smarca2 and therapeutic uses thereof" on Thu, June 8, 2023

Filed a patent for "bifunctional compounds for degrading btk with enhanced imid activity" on Mon, January 22, 2024

Filed a patent for "combination therapies with cbl-b inhibitor compounds and antiemetic agents" on Wed, June 22, 2022

Filed a patent for "substituted benzyl-triazole compounds for cbl-b inhibition, and further uses thereof" on Thu, May 18, 2023

Filed a patent for "3-substituted piperidine compounds for cbl-b inhibition, and use thereof" on Thu, December 1, 2022

Filed a patent for "piperidinylpyrazine-carboxamide compounds for treating and preventing cancer and for degrading btk" on Fri, July 22, 2022

Filed a patent for "bifunctional compounds for degrading btk via ubiquitin proteosome pathway" on Thu, January 26, 2023

Filed a patent for "bifunctional degraders of interleukin-1 receptor-associated kinases and therapeutic use thereof" on Thu, May 11, 2023

Filed a patent for "substituted pyrrolo[1,2-b]pyridazines as bifunctional degraders of interleukin-1 receptor-associated kinases" on Thu, April 20, 2023

Filed a patent for "piperidinylpyrazine-carboxamide compounds for treating and preventing cancer and for degrading btk" on Thu, May 18, 2023

Filed a patent for "bifunctional degraders of hematopoietic progenitor kinase and therapeutic uses thereof" on Thu, January 18, 2024

Filed a patent for "cyano cyclobutyl compounds for cbl-b inhibition and uses thereof" on Thu, July 6, 2023

Filed a patent for "bifunctional compounds for degrading btk via ubiquitin proteosome pathway" on Thu, July 20, 2023

Filed a patent for "combination therapies with cbl-b inhibitor compounds and antiemetic agents" on Thu, December 28, 2023

Filed a patent for "biomarkers for cbl, and compositions and methods for their use" on Thu, November 9, 2023

Filed a patent for "bifunctional compounds for degrading btk via ubiquitin proteosome pathway" on Thu, April 18, 2024

Filed a patent for "compounds for inhibiting or degrading itk, compositions, comprising the same methods of their making and methods of their use" on Fri, November 3, 2023

Filed a patent for "combination therapies with cbl-b inhibitor compounds" on Thu, October 27, 2022

Filed a patent for "biomarkers for cbl, and compositions and methods for their use" on Tue, April 19, 2022

Filed a patent for "biomarkers for cbl, and compositions and methods for their use" on Mon, May 9, 2022

Filed a patent for "compounds for inhibiting or degrading target proteins, compositions, comprising the same, methods of their making, and methods of their use" on Thu, May 25, 2023